Cargando…
SUN-323 Somatostatin Analogue: An Effective Treatment for Pseudoglucagonoma Syndrome
INTRODUCTION: Pseudoglucagonoma syndrome (PS) refers to the presence of necrolytic migratory erythema (NME), despite normal glucagon levels, and absence of a glucagon-secreting tumor. We present a case of PS successfully treated with octreotide. CASE PRESENTATION: A 42-year-old woman with history of...
Autores principales: | Vallejo Garcia, Franco, Rodriguez, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552871/ http://dx.doi.org/10.1210/js.2019-SUN-323 |
Ejemplares similares
-
THU536 Pseudoglucagonoma Syndrome: A Rare Complication After Partial Pancreatectomy
por: Monsour, Elio Paul, et al.
Publicado: (2023) -
SAT-127 Localization and Treatment of the Ectopic ACTH Syndrome Using Somatostatin Analogues
por: Mago, Sheena, et al.
Publicado: (2020) -
SAT-LB24 Association of Expression of Somatostatin Receptor 2 Subtype in Non-Pituitary Neuroendocrine Tumors With Response to Treatment With Somatostatin Analogues
por: Siddiqui, Abdullah, et al.
Publicado: (2020) -
SUN-118 Somatostatin Agonist Conjugated to the Evans Blue Moiety Is a Superior Analog in the Diagnosis and Treatment of Tumors Characterized by High Somatostatin Receptor Expression
por: Thakur, Shilpa, et al.
Publicado: (2020) -
SAT-323 Thoracic Paraganglioma Presenting with Recurrent Cerebrovascular Events
por: Qureshi, Maham, et al.
Publicado: (2019)